April 3, 2017
Tagrisso Gains Regular FDA Approval for NSCLC – MPR
The Food and Drug Administration (FDA) has approved Tagrisso (osimertinib; AstraZeneca) for the treatment of patients with metastatic…
April 3, 2017
Canopy Biosciences Acquires Rights to New Johns Hopkins, WUSTL Gene-Editing Tech – GenomeWeb
Research tools developer Canopy Biosciences announced today that it has exclusively licensed a novel gene-editing…
April 3, 2017
Independence’s digital health partnership provides seed capital to first company – IBX Newsroom
Independence Health Group, Ben Franklin Technology Partners of Southeastern Pennsylvania, and Safeguard Scientifics, Inc. have…
April 3, 2017
This Johns Hopkins startup has a new way to regrow soft tissue – Technical.ly Baltimore
Doctors can rebuild parts of the body that have been damaged, but they need soft…
April 3, 2017
Join us in Baltimore at IMET for Startup CFO
When: Tuesday, April 11, 2017 from 5:30 PM to 7:30 PM EDT Add to Calendar…
April 3, 2017
Emergent BioSolutions Signs $53 Million Modification to BARDA Contract for the Manufacture of Botulism Antitoxin
Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed a modification to its contract…